Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /

Схожие документы

• Continuous processing in pharmaceutical manufacturing /
  Опубликовано: (2015)
• Biomedical chromatography
  Опубликовано: (2010)
• Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
  по: Willig, Sidney H., 1919-
  Опубликовано: (2000)
• WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
  Опубликовано: (2008)
• The war against counterfeit medicine my story /
  по: Akunyili, Dora Nkem
  Опубликовано: (2011)